GMP IPO Watch
Baroda BNP Paribas Innovation Fund
Direct Plan · Growth Option · Baroda BNP Paribas Mutual Fund
Returns
Annualised (CAGR) returns for periods over a year.
Want to invest in this fund?
Open a free demat & trading account with Zerodha to invest in direct mutual funds with zero commission.
Rank in Category
| Period | This Fund | Category Avg. | Rank |
|---|---|---|---|
| 1W | -1.01% | -1.28% | 111 of 255 |
| 1M | -3.83% | -4.58% | 69 of 253 |
| 3M | +0.02% | -2.57% | 62 of 251 |
| 6M | +14.63% | +11.42% | 78 of 251 |
| YTD | +5.70% | -0.16% | 63 of 255 |
| 1Y | +8.97% | +2.02% | 50 of 228 |
| 2Y | +2.82% | -0.19% | 55 of 183 |
| INCEPTION | +12.83% | — | — |
Ranked among: Equity Scheme - Sectoral/ Thematic.
Rolling Returns
| Period | Average | Best | Worst | Positive Periods | Consistency |
|---|---|---|---|---|---|
| 3M | +3.75% | +20.69% | -20.26% | 71% | 28% |
| 6M | +5.28% | +32.75% | -20.17% | 68% | 27% |
| 1Y | +6.96% | +20.50% | -6.13% | 85% | 36% |
| 2Y | +7.62% | +13.11% | +1.35% | 100% | 43% |
Rolling returns show the average, best and worst outcome an investor would have seen entering at any point in the window.
NAV History
AUM Trend (₹ Cr, quarterly average)
Expense Ratio Trend
Portfolio · Aug 2026
Asset Allocation
- Equity94.27%
- Debt1.14%
- Cash-0.08%
- Other4.67%
Market Cap Split
- Large Cap31.64%
- Mid Cap35.20%
- Small Cap27.40%
- Others5.76%
Fundamentals
| Fund | Category | |
|---|---|---|
| P/E | 45.02 | 29.02 |
| P/B | 7.97 | 4.72 |
| Price / Sales | 5.90 | 3.42 |
| Price / Cash Flow | 30.87 | 21.70 |
| Dividend Yield (%) | 0.42 | 1.17 |
Holdings · Aug 2026
| Holding | Sector | Weight | Change (1M) |
|---|---|---|---|
| One 97 Communications | Financial Technology (Fintech) | 5.05% | +0.47% |
| Divis Laboratories | Pharmaceuticals & Biotechnology | 4.13% | +0.53% |
| Linde | Chemicals & Petrochemicals | 3.85% | -0.32% |
| Hitachi Energy | Electrical Equipment | 3.64% | +0.40% |
| Acutaas Chemicals | Pharmaceuticals & Biotechnology | 3.44% | -0.03% |
| Navin Fluorine International | Chemicals & Petrochemicals | 3.40% | +0.10% |
| Bosch | Auto Components | 3.27% | +0.51% |
| TVS Motors | Automobiles | 3.24% | -0.06% |
| Eternal | Retailing | 3.04% | +0.17% |
| MCX | Capital Markets | 3.00% | +0.29% |
| Nykaa | Retailing | 2.82% | +0.06% |
| Amagi Media Labs | IT - Services | 2.50% | -0.59% |
| Bajaj Finance | Finance | 2.49% | -0.50% |
| Bharat Electronics | Aerospace & Defense | 2.48% | +0.09% |
| Glenmark Pharmaceuticals | Pharmaceuticals & Biotechnology | 2.43% | +0.18% |
View all 50 holdings
| Lenskart Solutions | Retailing | 2.34% | -0.48% |
| 3M India | Diversified | 2.27% | -0.15% |
| Polycab | Industrial Products | 2.26% | +0.02% |
| Mahindra & Mahindra | Automobiles | 2.25% | -0.14% |
| Pine Labs | Financial Technology (Fintech) | 2.23% | +0.29% |
| Lupin | Pharmaceuticals & Biotechnology | 2.15% | -0.28% |
| Sagility | IT - Services | 2.15% | +0.08% |
| PB FinTech | Financial Technology (Fintech) | 2.02% | +0.33% |
| Max Financial Services | Insurance | 1.98% | +0.04% |
| Bharti Airtel | Telecom - Services | 1.97% | -0.24% |
| Delhivery | Transport Services | 1.79% | -0.15% |
| Cummins | Industrial Products | 1.75% | -0.72% |
| Groww | Capital Markets | 1.69% | -0.07% |
| GE Vernova T&D | Electrical Equipment | 1.65% | +0.01% |
| BSE | Capital Markets | 1.61% | -0.22% |
| Travel Food Services | Leisure Services | 1.27% | -0.36% |
| Concord Biotech | Pharmaceuticals & Biotechnology | 1.26% | -0.01% |
| Fractal Analytics | IT - Software | 1.25% | +0.02% |
| Persistent Systems | IT - Software | 1.22% | -0.02% |
| 360 One WAM | Capital Markets | 1.15% | +0.01% |
| Infosys | IT - Software | 1.09% | -0.02% |
| 182 Days Tbill (MD 03/09/2026) | Money Market | 1.09% | -0.02% |
| Ujjivan Small Finance Bank | Banks | 1.08% | -0.22% |
| Amber Enterprises | Consumer Durables | 1.04% | +0.00% |
| Physicswallah | Other Consumer Services | 0.91% | -0.10% |
| Aequs | Aerospace & Defense | 0.87% | +0.03% |
| Ola Electric Mobility | Automobiles | 0.81% | -0.33% |
| Jtekt | Auto Components | 0.76% | -0.12% |
| KFin Technologies | Capital Markets | 0.74% | +0.01% |
| AstraZeneca Pharma | Pharmaceuticals & Biotechnology | 0.68% | -0.14% |
| Fine Organic Industries | Chemicals & Petrochemicals | 0.67% | +0.04% |
| Atul | Chemicals & Petrochemicals | 0.55% | -0.05% |
| 6% TVS Motor Company Limited ** | Debt | 0.05% | -0.01% |
| Symbiotec Pharmalab | Pharmaceuticals & Biotechnology | 0.03% | — |
| Net Receivables / (Payables) | Net Current Assets | -0.08% | — |
Sector Allocation · Aug 2026
View all 21 sectors
Risk Metrics
Standard Deviation
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | 18.81 | — | High Volatility |
What is this?
Risk as measured by standard deviation is a statistical measure that quantifies the amount of variation or dispersion in a set of data points relative to its mean (average).
Sharpe Ratio
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | 0.36 | — | Good Risk Adjusted Returns |
What is this?
Higher the value means that fund has been able to give better returns for the amount of risk taken. It helps investors understand the return of an investment compared to its risk, showing whether the returns are due to intelligent investing or simply taking on excess risk. It is calculated by subtracting the risk-free return, defined as an Indian Government Bond, from the fund's returns, and then dividing by the standard deviation of returns.
Sortino Ratio
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | 0.58 | — | Good Risk Adjusted Returns |
What is this?
The Sortino Ratio is a financial metric used to measure the risk-adjusted return of an investment. It's a modification of the Sharpe Ratio but with a key difference; it only considers downside risk (the risk of negative returns), rather than total volatility. This means it focuses on how well an investment performs relative to the volatility that leads to losses, ignoring the volatility that results in gains. The idea is that investors are primarily concerned with minimizing losses, and positive volatility is generally seen as a good thing.
Compare With Peers
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
|
Nippon India Taiwan Equity Fund
Regular Plan · IDCW option
|
+125.07% | +61.55% | — | +32.55% |
|
Franklin Asian Equity Fund
Regular Plan · IDCW
|
+31.28% | +22.70% | +6.52% | +4.42% |
|
Nippon India Japan Equity Fund
Regular Plan · Bonus Option
|
+28.99% | +22.97% | +10.76% | +9.17% |
|
Motilal Oswal Active Momentum Fund
Direct Plan · Growth
|
+26.04% | — | — | +27.23% |
|
HDFC Pharma and Healthcare Fund
Direct Plan · IDCW Option
|
+25.57% | +29.81% | — | +29.73% |
|
Kotak Healthcare Fund
Regular Plan · IDCW Option
|
+25.46% | — | — | +19.77% |
|
PGIM India Healthcare Fund
Direct Plan · Direct IDCW
|
+24.20% | — | — | +11.25% |
|
Motilal Oswal Special Opportunities Fund
Direct Plan · Growth
|
+19.68% | — | — | +19.59% |
|
HSBC India Export Opportunities Fund
Direct Plan · Growth
|
+19.63% | — | — | +8.42% |
|
Edelweiss Recently Listed IPO Fund
Regular Plan · Growth
|
+19.17% | +15.58% | +9.91% | +14.76% |
More From Baroda BNP Paribas Asset Management India Private Limited
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
|
Baroda BNP Paribas Gold ETF
Regular Plan · Growth Option
|
+25.19% | — | — | +34.68% |
|
Baroda BNP Paribas Gold ETF Fund of Fund
Direct Plan · Growth Option
|
+24.06% | — | — | +39.67% |
|
Baroda BNP Paribas Health and Wellness Fund
Direct Plan · IDCW Option
|
+10.57% | — | — | +4.37% |
|
Baroda BNP Paribas Manufacturing Fund
Direct Plan · IDCW Option
|
+8.30% | — | — | +3.28% |
|
Baroda BNP Paribas Aqua Fund of Fund
Direct Plan · IDCW Option
|
+8.14% | +15.08% | — | +11.66% |
|
Baroda BNP Paribas Small Cap Fund
Direct Plan · Growth Option
|
+7.84% | — | — | +13.19% |
|
Baroda BNP Paribas Multi Asset Active Fund of Funds
Direct Plan · Growth Option
|
+7.44% | — | — | +9.58% |
|
Baroda BNP Paribas Credit Risk Fund (scheme has Two segregated portfolios)
Direct Plan · Growth Option
|
+7.05% | +8.36% | +9.33% | +8.73% |
|
Baroda BNP Paribas Ultra Short Term Fund
Direct Plan · Growth Option
|
+6.58% | +7.22% | +6.69% | +6.52% |
|
Baroda BNP Paribas Money Market Fund
Direct Plan · Growth Option
|
+6.52% | +7.26% | +6.50% | +5.89% |
About This Scheme
Investment Objective
The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of companies focusing and benefitting from innovation.
Stated Asset Allocation
Equity & Equity related instruments of companies belonging to the innovation theme : 80% 100% Equity and equity related instruments of any other companies : 0% 20% Money Market and other liquid instruments*, Gold and Silver instruments (through ETFs): 0% 20% Units issued by INvITs : 0% 10% Units of Mutual Funds as permitted by SEBI$ : 0% 10%
Exit Load
If units of the Scheme are redeemed or switched out up to 10% of the units (the limit) within 1 year from the date of allotment - Nil. • If units of the scheme are redeemed or switched out in excess of the limit within 1 year from the date of allotment - 1% of the applicable NAV. • If units of scheme are redeemed or switched out after 1 year from the date of allotment - Nil.
Fund Managers
Mr. Jitendra Sriram, Mr. Abhay Joshi
Mr. Jitendra Sriram(Primary Fund Manager), Mr. Abhay Joshi (Research Analyst & Co- Fund Manager)
Mutual fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not indicative of future returns. Data is sourced from AMFI and fund houses via FinAPI and may lag official figures.